The FDA warnings that apply to their medications
Semaglutide targets GLP-1 receptors , which control appetite and blood sugar
When it fails, the consequences can be severe
The FDA label does not specify a particular time of day for Zepbound administration
Loss of red blood cells from the bloodstream includes acute blood loss, such as aortic aneurysm rupture, hemorrhage from trauma, surgery, or childbirth, or chronic blood loss that later causes iron deficiency, such as heavy menstruation, aortic aneurysm, peptic ulcer, hemorrhoids, or colon cancer
The insurer was paying $1,000 or more per month for medications that the majority of recipients would abandon within months, often without achieving the weight loss or metabolic improvements that justified the expense in the first place